Perimenopause: Causes, Symptoms, Diagnosis, and Treatment Options

Perimenopause: Causes, Symptoms, Diagnosis, and Treatment Options

Perimenopause is the natural transition leading up to menopause, when the ovaries gradually change how they produce reproductive hormones. During this time, fluctuations in estrogen and progesterone can affect menstrual cycles, sleep, body temperature regulation, mood, and sexual health.

For some women, perimenopause causes relatively few symptoms. Others experience hot flashes, irregular periods, sleep disturbances, mood changes, vaginal discomfort, or other symptoms that significantly affect daily life.

Perimenopause often begins in the 40s, although changes may start earlier. The transition can last several years and ends when menopause is reached, which is generally confirmed after 12 consecutive months without a menstrual period when no other cause explains the absence of bleeding.

Because symptoms vary and hormone levels fluctuate, recognizing perimenopause is not always straightforward. Understanding the causes, symptoms, diagnostic approach, and available treatment options can help women make informed decisions about their health.

Causes of Perimenopause

Perimenopause occurs primarily because of age-related changes in ovarian function. As the number and activity of ovarian follicles decline, ovulation becomes less predictable and reproductive hormone production changes.

These changes are part of the natural reproductive aging process, although their timing and effects vary.

Fluctuating Estrogen Levels

Estrogen helps regulate menstrual cycles, body temperature, vaginal tissue health, and several other functions.

During perimenopause, estrogen levels do not simply decline in a steady pattern. They can rise and fall substantially from one menstrual cycle to another.

These fluctuations may contribute to:

  • Hot flashes and night sweats
  • Irregular menstrual bleeding
  • Breast tenderness
  • Vaginal dryness
  • Changes in sleep and mood

Because estrogen levels can vary widely, a single hormone measurement may not reflect a woman’s overall hormonal transition.

Changes in Progesterone Production

Progesterone is produced primarily after ovulation.

As ovulation becomes less frequent or less predictable during perimenopause, progesterone production may also become irregular.

This can contribute to changes in menstrual cycle timing and bleeding patterns.

Some women experience shorter cycles early in the transition, followed by longer intervals between periods as menopause approaches.

Changes in Ovarian Follicle Activity

Women are born with a finite number of ovarian follicles.

Over time, the number of remaining follicles decreases, and the ovaries respond differently to hormonal signals from the brain.

These changes affect the timing of ovulation and the production of estrogen and progesterone.

The transition continues until ovarian activity has declined sufficiently for menstrual periods to stop permanently.

Factors That May Influence the Timing of Perimenopause

Although reproductive aging is the underlying process, several factors may influence when menopause occurs.

These include:

  • Family history: The timing of menopause often shows familial patterns.
  • Smoking: Smoking is associated with earlier menopause.
  • Certain cancer treatments: Chemotherapy or pelvic radiation may affect ovarian function.
  • Ovarian surgery: Procedures affecting ovarian tissue can influence reproductive hormone production.
  • Certain medical conditions: Some genetic or autoimmune conditions may contribute to earlier ovarian insufficiency.

These factors do not necessarily determine when an individual will enter perimenopause.

Menstrual changes before age 40 require evaluation for other conditions, including primary ovarian insufficiency, rather than automatically being attributed to typical perimenopause.

Symptoms of Perimenopause

Perimenopause symptoms differ widely in type, severity, and duration.

Some women primarily notice menstrual changes, while others experience symptoms affecting sleep, emotional well-being, or sexual health.

Irregular Menstrual Periods

Changes in menstrual patterns are among the most recognizable signs of perimenopause.

Periods may become:

  • More frequent or less frequent
  • Shorter or longer
  • Heavier or lighter
  • Less predictable

Skipped periods may become more common as menopause approaches.

However, not every change in bleeding is caused by perimenopause.

Very heavy bleeding, bleeding between periods, or bleeding after sexual intercourse may require evaluation for other causes.

Any bleeding after menopause has been established should be medically assessed.

Hot Flashes

Hot flashes, also called vasomotor symptoms, are sudden sensations of heat that may affect the face, neck, chest, or entire body.

They may be accompanied by:

  • Sweating
  • Flushing
  • A rapid heartbeat
  • Chills after the sensation passes

Hot flashes can occur during the day or at night.

Their frequency and severity vary, and some women experience symptoms for several years.

Night Sweats

Night sweats are episodes of sweating during sleep, often associated with hot flashes.

They may interrupt sleep, require changing clothing or bedding, and contribute to daytime fatigue.

Repeated sleep disruption can affect concentration, mood, and overall quality of life.

Sleep Disturbances

Women in perimenopause may experience difficulty falling asleep, staying asleep, or returning to sleep after waking.

Hot flashes and night sweats are common contributors, but sleep changes can also occur independently.

Other conditions, including insomnia, sleep apnea, and mood disorders, may contribute to sleep problems and should be considered when symptoms persist.

Mood Changes and Anxiety

Hormonal fluctuations and sleep disruption may contribute to changes in emotional well-being.

Some women experience:

  • Increased irritability or rage
  • Anxiety
  • Mood swings
  • Lower stress tolerance
  • Depressive symptoms

The menopause transition is associated with an increased vulnerability to depression in some individuals.

However, significant mood symptoms should not automatically be attributed to hormones alone.

Difficulty Concentrating and Memory Concerns

Some women report forgetfulness, difficulty concentrating, or a sensation commonly described as brain fog.

These symptoms may be influenced by sleep disturbances, stress, mood changes, and the hormonal transition.

Persistent or progressive cognitive changes require appropriate evaluation rather than being assumed to result from perimenopause.

Vaginal Dryness and Painful Intercourse

Changes in estrogen levels can affect vaginal and vulvar tissues.

Symptoms may include:

  • Vaginal dryness
  • Burning or irritation
  • Discomfort during sexual activity
  • Reduced lubrication

These symptoms may become more noticeable as estrogen levels decline and can persist or progress after menopause.

Changes in Sexual Desire

Some women notice changes in libido during perimenopause.

Sexual desire is influenced by many factors, including hormonal changes, relationship circumstances, stress, sleep, mood, medications, and physical comfort.

Painful intercourse or vaginal dryness may also affect sexual interest.

Urinary Symptoms

Hormonal changes may contribute to urinary urgency, recurrent urinary tract infections, or discomfort involving the urinary and genital tissues.

However, urinary symptoms can have several causes, and evaluation may be needed to identify the appropriate treatment.

Joint Discomfort and Body Composition Changes

Some women experience joint aches or notice changes in body fat distribution during midlife.

Aging, physical activity, sleep, metabolic factors, and hormonal changes may all contribute.

Weight gain is not inevitable during perimenopause, and hormone therapy is not prescribed specifically as a weight-loss treatment.

How Is Perimenopause Diagnosed?

Perimenopause is generally identified through menstrual history, symptoms, age, and clinical assessment.

No single test that definitively diagnoses the transition in every patient.

Medical History and Symptom Review

A healthcare professional may ask about:

  • Menstrual cycle changes
  • Hot flashes and night sweats
  • Sleep quality
  • Mood symptoms
  • Vaginal and urinary concerns
  • Sexual health
  • Medications and contraception
  • Pregnancy possibility
  • Personal and family medical history

Patterns over time are often more informative than a single symptom or laboratory result.

Menstrual Cycle Changes

Changes in menstrual cycle timing are central to identifying the menopausal transition.

The STRAW+10 reproductive aging framework describes early and late stages of the menopause transition.

In the early transition, a persistent difference of seven days or more between consecutive menstrual cycle lengths may occur.

In the late transition, intervals of 60 days or longer without menstruation become more common.

These patterns help describe reproductive aging but are not a substitute for individualized clinical evaluation.

Hormone Testing

Follicle-stimulating hormone (FSH) and estradiol levels may change during perimenopause.

However, both hormones can fluctuate significantly.

For otherwise healthy women aged 45 or older with typical symptoms and menstrual changes, routine hormone testing is generally not necessary to identify perimenopause.

Testing may be considered in selected situations, especially when symptoms occur at an unusually young age, or the diagnosis is uncertain.

A single normal FSH or estradiol result does not rule out perimenopause.

Ruling Out Other Conditions

Some symptoms associated with perimenopause can also occur with other medical conditions.

Depending on the presentation, evaluation may consider:

  • Pregnancy
  • Thyroid disorders
  • Anemia
  • Abnormal uterine bleeding disorders
  • Medication effects
  • Depression or anxiety disorders
  • Sleep disorders

For example, unusually heavy bleeding may require blood tests, pelvic ultrasound imaging, or endometrial evaluation through biopsy depending on age and risk factors.

Perimenopause and Hormonal Contraception

Hormonal contraception can alter bleeding patterns and suppress some hormonal changes.

This may make it difficult to determine whether natural menstrual cycles are becoming irregular.

Contraception decisions during perimenopause should consider pregnancy risk, medical history, symptoms, and the type of contraceptive method used.

Pregnancy remains possible during perimenopause until menopause has been established.

Treatment Options for Perimenopause

Treatment depends on the symptoms being experienced, their severity, medical history, pregnancy potential, and individual preferences.

Not everyone requires medication.

For women whose symptoms interfere with daily activities, several evidence-based treatment options are available.

Menopausal Hormone Therapy

Menopausal hormone therapy is an effective treatment for bothersome hot flashes and night sweats.

Systemic hormone therapy generally involves estrogen, with an appropriate bioidentical progesterone or synthetic progestin added for women who have a uterus to reduce the risk of endometrial cancer.

Treatment may be available in different forms, including:

  • Oral tablets
  • Transdermal patches
  • Gels
  • Sprays

Injections and vaginal rings are also available, although less commonly used. 

The appropriate formulation depends on individual risk factors, symptoms, and preferences.

For many healthy women younger than 60 or within 10 years of menopause onset, the benefit-risk balance of hormone therapy is generally favorable for treating bothersome vasomotor symptoms when no contraindications are present.

However, hormone therapy is not appropriate for everyone.

Relevant considerations include a history of certain cancers, unexplained vaginal bleeding, blood clots, stroke, liver disease, and other medical conditions.

Menopausal hormone therapy is not contraception. Women who may become pregnant still need appropriate pregnancy prevention if pregnancy is not desired.

FDA-Approved Bioidentical Hormone Therapy

The term bioidentical describes hormones that are chemically identical to hormones produced by the human body.

Certain FDA-approved estradiol and micronized progesterone products are bioidentical.

These medications have undergone regulatory review for quality, safety, and effectiveness for their approved uses.

Custom-compounded bioidentical hormone products are different from FDA-approved formulations. Compounded products generally lack the same regulatory review and are not recommended routinely when appropriate FDA-approved options are available.

Compounded hormones can be a good option in certain situations, but the risks of the unregulated nature of custom-compounded medications should be considered. 

The term bioidentical does not mean a hormone treatment is risk-free.

Hormonal Contraceptives

For some women in perimenopause who still need contraception, traditional combined hormonal contraceptives may help manage irregular bleeding and certain hormonal symptoms.

They can also provide pregnancy prevention.

However, traditional combined hormonal contraceptives may not be appropriate for women with certain cardiovascular risk factors, migraine with aura, a history of blood clots, or other contraindications.

Progestin-only methods or intrauterine devices may be considered as an alternative in appropriate clinical scenarios. These can be used alongside bioidentical estrogen products utilized for menopausal hormone therapy, which has a more favorable risk profile than the synthetic estrogen types used in traditional birth control methods.

Treatment selection should account for both symptom management and contraceptive needs.

Nonhormonal Medications for Hot Flashes

Women who cannot or prefer not to use hormone therapy may benefit from nonhormonal treatments.

Evidence-supported prescription options include certain antidepressants, such as selected selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), and other medications.

Veozah and Lynkuet are nonhormonal neurokinin 3 receptor antagonists and are both approved for the treatment of moderate to severe vasomotor symptoms associated with menopause.

They require regular liver function lab testing prior to starting and during treatment, as they carry a warning for rare but serious liver injury.

Medication choice depends on individual risks, potential interactions, symptom severity, and current prescribing guidance.

Treatment for Vaginal Dryness and Painful Intercourse

Vaginal dryness and discomfort may respond to:

  • Vaginal moisturizers
  • Lubricants during sexual activity
  • Low-dose vaginal estrogen
  • Other prescription therapies for genitourinary symptoms of menopause

Low-dose vaginal estrogen acts primarily on local tissues and generally produces much lower systemic hormone exposure than systemic hormone therapy.

Treatment selection depends on symptoms, medical history, and individual preferences.

Lifestyle and Symptom Management

Lifestyle practices can support overall health during perimenopause, although they may not eliminate hormonally driven symptoms.

Helpful approaches may include:

  • Regular physical activity
  • Strength or resistance training
  • Balanced nutrition
  • Consistent sleep routines
  • Avoiding smoking
  • Limiting alcohol when appropriate
  • Identifying personal hot flash triggers
  • Maintaining a comfortable sleeping environment

Cognitive behavioral therapy (CBT) has evidence for reducing the impact of bothersome vasomotor symptoms and can also help with insomnia.

Clinical hypnosis is another evidence-supported nonhormonal approach for vasomotor symptoms.

Managing Sleep Problems

When sleep disruption is related to night sweats, treating vasomotor symptoms may improve sleep.

Hormone therapy using micronized progesterone can also help with sleep due to its effect on GABA receptors in the brain, which creates a mild sedative effect. 

Cognitive behavioral therapy for insomnia (CBT-I) is also a first-line treatment for chronic insomnia.

Persistent sleep problems may also warrant assessment for sleep apnea, mood disorders, medication effects, or other causes.

Mental Health Support

Significant anxiety, depression, or mood changes deserve appropriate assessment and treatment.

Depending on the situation, options may include psychotherapy, medication, sleep-focused treatment, or a combination of approaches.

Hormone therapy can have a positive effect on mood during perimenopause; however, it should not be assumed to replace established treatment for a diagnosed mood disorder.

Managing Abnormal Menstrual Bleeding

Irregular bleeding can occur during perimenopause, but persistent heavy bleeding or unusual bleeding patterns should be evaluated.

Management depends on the cause and may include hormonal contraception, progestin treatment, a levonorgestrel-releasing intrauterine device, or other interventions.

Treatment should follow appropriate investigation rather than assuming all bleeding changes are caused by perimenopause.

Preventive Health During Perimenopause

Perimenopause is also an opportunity to review long-term health.

Important considerations may include:

  • Blood pressure and cardiovascular risk
  • Cholesterol and blood glucose
  • Bone health
  • Breast and cervical cancer screening
  • Sleep and mental health
  • Physical activity and nutrition

Menopausal hormone therapy has been shown to decrease cardiovascular risk when started before age 60 or within 10 years of menopause, but currently is not recommended or FDA-approved to be used solely to prevent heart disease.

Frequently Asked Questions

At what age does perimenopause usually begin?

Perimenopause often begins during the 40s, although some women notice changes earlier. The timing varies based on individual reproductive aging and other factors. Symptoms or menstrual changes before age 40 should be evaluated for possible causes, including primary ovarian insufficiency.

How long does perimenopause last?

Perimenopause commonly lasts several years, but the duration varies considerably. Some women experience a relatively short transition, while others have symptoms or menstrual irregularity over a longer period. Menopause is generally confirmed after 12 consecutive months without menstruation when no other cause explains the absence of periods.

Can you be in perimenopause if your periods are still regular?

Yes. Some women experience hot flashes, sleep disturbances, or other symptoms before menstrual changes become obvious. However, these symptoms can have other causes, so a clinical assessment may be helpful when symptoms persist or interfere with daily life.

Can a blood test confirm perimenopause?

Usually not. FSH and estrogen levels fluctuate during the menopausal transition, so a single blood test cannot reliably confirm or exclude perimenopause. For many women aged 45 or older with typical symptoms, diagnosis is based primarily on menstrual history and clinical findings.

Can you get pregnant during perimenopause?

Yes. Ovulation may become irregular and egg quality declines with age, but pregnancy remains possible. Menopausal hormone therapy does not prevent pregnancy. Women who do not wish to become pregnant should discuss appropriate contraception until it is no longer needed.

Is hormone therapy safe during perimenopause?

Hormone therapy can be an appropriate and effective option for many women with bothersome symptoms. Its safety depends on medical history, age, treatment type, dose, and individual risk factors. Women with certain conditions may need alternatives. A personalized benefit-risk assessment is important before starting treatment

Does perimenopause cause weight gain?

Perimenopause can contribute to changes in body fat distribution, particularly increased abdominal fat, but weight changes are also influenced by aging, activity, sleep, and metabolic factors. Weight gain is not inevitable, and menopausal hormone therapy is not prescribed specifically for weight loss.

References

  1. The Menopause Society — Menopause Topics — Patient education on perimenopause, menopause symptoms, and treatment options.
  2. The Menopause Society — The 2022 Hormone Therapy Position Statement — Evidence-based recommendations regarding systemic hormone therapy benefits, risks, and treatment selection.
  3. The Menopause Society — The 2023 Nonhormone Therapy Position Statement — Evidence-based nonhormonal options for vasomotor symptoms.
  4. National Institute on Aging — What Is Menopause? — Overview of menopause and the menopausal transition.
  5. NICE Guideline NG23 — Menopause: Identification and Management — Guidance on clinical diagnosis and management of menopause-related symptoms.
  6. U.S. Food and Drug Administration — Menopause — Information about hormone therapy, treatment safety, and menopause-related concerns.
  7. U.S. Food and Drug Administration — Veozah (Fezolinetant) Drug Safety Communication — Safety information and liver monitoring requirements for fezolinetant.

Treatments We Offer: